About
Ardelyx Inc (NASDAQ:ARDX) — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings
Apr 23 2026
Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026
Apr 20 2026
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
Apr 16 2026
Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026
Apr 1 2026
Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx
Financials
Revenue
$407.32 M
Market Cap
$1.46 B
EPS
-0.26
Translate